International Patent: MODIFIED FLAVIVIRUS NUCLEOTIDE SEQUENCE, USE OF THE NUCLEOTIDE SEQUENCE, THERAPEUTIC AGENT, USE OF AN ONCOLYTIC VIRUS, VIRAL VECTOR, PROCESS FOR OBTAINING SAME AND METHOD OF TREATMENT

GENEVA, Sept. 7 -- IOZ BIOTECH LTDA filed a patent application (BR2026/050091) for “MODIFIED FLAVIVIRUS NUCLEOTIDE SEQUENCE, USE OF THE NUCLEOTIDE SEQUENCE, THERAPEUTIC AGENT, USE OF AN ONCOLYTIC VIRUS, VIRAL VECTOR, PROCESS FOR OBTAINING SAME AND METHOD OF TREATMENT”. With publication no. WO/2026/178612, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/86

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....